Product
ONCOFID P-B
Aliases
ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)
1 clinical trial
1 indication
Indication
Bladder Carcinoma in SituClinical trial
A Phase III, Single-arm Study to Evaluate the Efficacy and Safety of ONCOFID-P-B (Paclitaxel-hyaluronic Acid Conjugate) Administered Intravesically to Patients With BCG-unresponsive Carcinoma in Situ of the Bladder With or Without Ta-T1 Papillary Disease (Orion-BC)Status: Recruiting, Estimated PCD: 2025-11-01